宿主基因表达预测脓毒症进展
本研究为回顾性差异基因表达分析和预测建模,使用RNA测序数据,纳入4家大型学术医疗中心277例临床判定感染的住院患者。脓毒症进展定义为72小时内Sepsis-3分级升高;136例进展者与141例非进展者之间无显著差异表达基因。当进展定义为ICU入住或28天死亡时,识别出1178个差异表达基因,基于这些基因的模型预测进展的曲线下面积为0.71;4个既往基因标签预测28天死亡的受试者工作特征曲线下面积为0.70-0.75,标签间无显著差异。作者认为以Sepsis-3分级升高定义脓毒症进展不适合转录组预测框架,既往标签预测28天死亡准确性不足,无法提供有意义的临床效用。
要点
- 以72小时内Sepsis-3分级升高定义进展时,136例进展者与141例非进展者之间无显著差异表达基因。
- 以ICU入住或28天死亡定义进展时,识别出1178个差异表达基因,模型预测进展的AUC为0.71。
- 4个既往基因标签预测28天死亡的AUROC为0.70-0.75,标签间无显著差异。
- 作者认为以Sepsis-3分级升高定义脓毒症进展不是转录组预测方法的有效框架。
- 既往基因标签预测28天死亡准确性不足,无法提供有意义的临床效用。
适用人群与场景
- 4家大型学术医疗中心 enrolled 的277例临床判定感染的患者,考虑纳入本研究。
诊断标准与关键阈值
- 脓毒症进展定义为72小时内Sepsis-3分级升高。
- 替代进展定义包括ICU入住或28天死亡。
研究设计与关键结果
- 研究设计为回顾性差异基因表达分析和预测建模,使用全血RNA测序数据,纳入277例临床判定感染的患者。
- 以72小时内Sepsis-3分级升高定义进展时,136例进展者与141例非进展者之间无显著差异表达基因。
- 以ICU入住或28天死亡定义进展时,识别出1178个差异表达基因,基于这些基因的模型预测进展的AUC为0.71。
- 验证4个既往基因标签预测28天死亡,AUROC为0.70-0.75,标签间无显著差异。
证据类型、等级与局限
- 证据类型:回顾性差异基因表达分析和预测建模研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为以Sepsis-3分级升高定义脓毒症进展不是转录组预测方法的有效框架。
- 作者认为既往基因标签预测28天死亡准确性不足,无法提供有意义的临床效用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis causes significant mortality. However, most patients who die of sepsis do not present with severe infection, hampering efforts to deliver early, aggressive therapy. It is also known that the host gene expression response to infection precedes clinical illness. This study seeks to develop transcriptomic models to predict progression to sepsis or shock within 72 hours of hospitalization and to validate previously identified transcriptomic signatures in the prediction of 28-day mortality.
DESIGN: Retrospective differential gene expression analysis and predictive modeling using RNA sequencing data.
PATIENTS: Two hundred seventy-seven patients enrolled at four large academic medical centers; all with clinically adjudicated infection were considered for inclusion in this study.
MEASUREMENTS AND MAIN RESULTS: Sepsis progression was defined as an increase in Sepsis 3 category within 72 hours. Transcriptomic data were generated using RNAseq of whole blood. Least absolute shrinkage and selection operator modeling was used to identify predictive signatures for various measures of disease progression. Four previously identified gene signatures were tested for their ability to predict 28-day mortality. There were no significant differentially expressed genes in 136 subjects with worsened Sepsis 3 category compared with 141 nonprogressor controls. There were 1,178 differentially expressed genes identified when sepsis progression was defined as ICU admission or 28-day mortality. A model based on these genes predicted progression with an area under the curve of 0.71. Validation of previously identified gene signatures to predict sepsis mortality revealed area under the receiver operating characteristic values of 0.70-0.75 and no significant difference between signatures.
CONCLUSIONS: Host gene expression was unable to predict sepsis progression when defined by an increase in Sepsis-3 category, suggesting this definition is not a useful framework for transcriptomic prediction methods. However, there was a differential response when progression was defined as ICU admission or death. Validation of previously described signatures predicted 28-day mortality with insufficient accuracy to offer meaningful clinical utility.
参考来源
- Fiorino C, Liu Y, Henao R, et al. Host Gene Expression to Predict Sepsis Progression. Crit Care Med. 2022. PMID: 36178298. doi:10.1097/CCM.0000000000005675
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。